Dopamine metabolism and neurotransmission in primate brain in relationship to monoamine oxidase A and B inhibition
Identifieur interne : 002552 ( Main/Exploration ); précédent : 002551; suivant : 002553Dopamine metabolism and neurotransmission in primate brain in relationship to monoamine oxidase A and B inhibition
Auteurs : H. Youdim [Israël] ; P. Riederer [Allemagne]Source :
- Journal of Neural Transmission / General Section JNT [ 0300-9564 ] ; 1993-06-01.
Abstract
Summary: The “cheese effect”, potentiation of sympathomimetic action of indirectly acting amines such as tyramine, the main side effect of irreversible nonselective and selective monoamine oxidase (MAO) A inhibitors, has largely been eliminated in the new generation of reversible selective MAO-A and B and irreversible MAO-B inhibitors. These selective inhibitors are demonstrating unique pharmacology and initial controlled clinical studies are providing evidence to support their action as anti-depressants and anti-Parkinson's disease drugs and possibly as neuroprotectors. Thirty years of experience with nonselective MAO inhibitors has resulted in a better understanding and management of the new generation of MAO inhibitors. Because of their selective action on the specific forms of MAO, which results in selective elevation of brain noradrenaline and serotonin on the one hand and dopamine and phenylethylamine on the other, it is hoped that these drugs will be able to elucidate the functional roles of MAO-A and B subtypes with regards to dopamine metabolism in the human brain.
Url:
DOI: 10.1007/BF01245231
Affiliations:
Links toward previous steps (curation, corpus...)
Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Dopamine metabolism and neurotransmission in primate brain in relationship to monoamine oxidase A and B inhibition</title><author><name sortKey="Youdim, H" sort="Youdim, H" uniqKey="Youdim H" first="H." last="Youdim">H. Youdim</name></author><author><name sortKey="Riederer, P" sort="Riederer, P" uniqKey="Riederer P" first="P." last="Riederer">P. Riederer</name></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:8BEDF6F24D7CBCC3A995F655D32AB52A022BF610</idno><date when="1993" year="1993">1993</date><idno type="doi">10.1007/BF01245231</idno><idno type="url">https://api.istex.fr/document/8BEDF6F24D7CBCC3A995F655D32AB52A022BF610/fulltext/pdf</idno><idno type="wicri:Area/Main/Corpus">001F93</idno><idno type="wicri:Area/Main/Curation">001C96</idno><idno type="wicri:Area/Main/Exploration">002552</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Dopamine metabolism and neurotransmission in primate brain in relationship to monoamine oxidase A and B inhibition</title><author><name sortKey="Youdim, H" sort="Youdim, H" uniqKey="Youdim H" first="H." last="Youdim">H. Youdim</name><affiliation wicri:level="1"><country xml:lang="fr">Israël</country><wicri:regionArea>Department of Pharmacology, Technion-Bruce Rappaport Faculty of Medicine, Haifa</wicri:regionArea><wicri:noRegion>Haifa</wicri:noRegion></affiliation></author><author><name sortKey="Riederer, P" sort="Riederer, P" uniqKey="Riederer P" first="P." last="Riederer">P. Riederer</name><affiliation wicri:level="3"><country xml:lang="fr">Allemagne</country><wicri:regionArea>Department of Psychiatry, University of Würzburg, Würzburg</wicri:regionArea><placeName><region type="land" nuts="1">Bavière</region><region type="district" nuts="2">District de Basse-Franconie</region><settlement type="city">Wurtzbourg</settlement></placeName></affiliation></author></analytic><monogr></monogr><series><title level="j">Journal of Neural Transmission / General Section JNT</title><title level="j" type="abbrev">J. Neural Transmission</title><idno type="ISSN">0300-9564</idno><idno type="eISSN">1435-1463</idno><imprint><publisher>Springer-Verlag</publisher><pubPlace>Vienna</pubPlace><date type="published" when="1993-06-01">1993-06-01</date><biblScope unit="volume">91</biblScope><biblScope unit="issue">2-3</biblScope><biblScope unit="page" from="181">181</biblScope><biblScope unit="page" to="195">195</biblScope></imprint><idno type="ISSN">0300-9564</idno></series><idno type="istex">8BEDF6F24D7CBCC3A995F655D32AB52A022BF610</idno><idno type="DOI">10.1007/BF01245231</idno><idno type="ArticleID">Art5</idno><idno type="ArticleID">BF01245231</idno></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">0300-9564</idno></seriesStmt></fileDesc><profileDesc><textClass></textClass><langUsage><language ident="en">en</language></langUsage></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Summary: The “cheese effect”, potentiation of sympathomimetic action of indirectly acting amines such as tyramine, the main side effect of irreversible nonselective and selective monoamine oxidase (MAO) A inhibitors, has largely been eliminated in the new generation of reversible selective MAO-A and B and irreversible MAO-B inhibitors. These selective inhibitors are demonstrating unique pharmacology and initial controlled clinical studies are providing evidence to support their action as anti-depressants and anti-Parkinson's disease drugs and possibly as neuroprotectors. Thirty years of experience with nonselective MAO inhibitors has resulted in a better understanding and management of the new generation of MAO inhibitors. Because of their selective action on the specific forms of MAO, which results in selective elevation of brain noradrenaline and serotonin on the one hand and dopamine and phenylethylamine on the other, it is hoped that these drugs will be able to elucidate the functional roles of MAO-A and B subtypes with regards to dopamine metabolism in the human brain.</div></front></TEI><affiliations><list><country><li>Allemagne</li><li>Israël</li></country><region><li>Bavière</li><li>District de Basse-Franconie</li></region><settlement><li>Wurtzbourg</li></settlement></list><tree><country name="Israël"><noRegion><name sortKey="Youdim, H" sort="Youdim, H" uniqKey="Youdim H" first="H." last="Youdim">H. Youdim</name></noRegion></country><country name="Allemagne"><region name="Bavière"><name sortKey="Riederer, P" sort="Riederer, P" uniqKey="Riederer P" first="P." last="Riederer">P. Riederer</name></region></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002552 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 002552 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= ParkinsonV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= ISTEX:8BEDF6F24D7CBCC3A995F655D32AB52A022BF610
|texte= Dopamine metabolism and neurotransmission in primate brain in relationship to monoamine oxidase A and B inhibition
}}
| This area was generated with Dilib version V0.6.23. |  |